ALDEYRA THERAPEUTICS, INC.

Insiders Aldeyra Therapeutics, Inc.

Equities

ALDX

US01438T1060

Market Closed - Nasdaq Other stock markets 01:30:00 10/05/2024 am IST			5-day change	1st Jan Change
3.94 ^USD	-3.19%		-6.41%	+12.25%

08/05	Aldeyra Therapeutics Enrolls First Patient in Phase 3 Dry Eye Chamber Study	MT
08/05	Aldeyra Therapeutics, Inc. Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aldeyra Therapeutics Insider Sold Shares Worth $580,760, According to a Recent SEC Filing	13/03	MT
Omega Therapeutics Hires Aldeyra Therapeutics Chief Financial Officer Joshua Reed for Same Role	29/22/29	MT
Aldeyra Therapeutics, Inc. Announces Management Changes, Effective May 10, 2022	29/22/29	CI
Insider Trends: Insider Buying Continued with Purchase of Aldeyra Therapeutics Stock	05/21/05	MT
Aldeyra Therapeutics, Inc. Announces Retirement of Jesse I. Treu from the Board of Directors	26/21/26	CI
Insider Trends: Insider Purchase of Aldeyra Therapeutics Stock Extends 90-Day Positive Trend	22/21/22	MT
Insider Trends: Insider Purchase Eases Back 90-Day Trend of Sales at Aldeyra Therapeutics	12/21/12	MT
Aldeyra Therapeutics, Inc. Announces Executive Changes	12/20/12	CI
Aldeyra Therapeutics, Inc. Appoints Paul Karpecki to Anterior Segment Scientific Advisory Board	28/20/28	CI
Aldeyra Therapeutics, Inc. Appoints Nancy Miller-Rich to Board of Directors	14/20/14	CI
Aldeyra Therapeutics Announces Promotion of Stephen G. Machatha, Ph.D. to Position of Senior Vice President of Technical Operations	15/19/15	CI
Aldeyra Therapeutics, Inc. Announces Promotion of David McMullin to Position of Chief Commercial Officer	03/19/03	CI
Aldeyra Therapeutics, Inc. Appoints David McMullin as Senior Vice President, Corporate Development and Strategy	10/18/10	CI
Aldeyra Therapeutics Appoints Richard H. Douglas to its Board of Directors	14/16/14	CI
Scott L. Young Steps Down from His Position as Chief Operating Officer of Aldeyra	02/16/02	CI
Aldeyra Therapeutics Appoints Mary Taylor, MPH as Senior Vice President, Regulatory Affairs	09/16/09	CI
Aldeyra Therapeutics, Inc. Appoints David J. Clark as Chief Medical Officer	11/16/11	CI
Aldeyra Therapeutics Expands Drug Development Team in Advance of NS2 Clinical Trials	02/14/02	CI
Aldeyra Therapeutics, Inc. Appoints Stephen Tulipano Chief Financial Officer, Effective from June 23, 2014	19/14/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW